## Core Concept
Methemoglobinemia is a disorder characterized by an abnormal amount of methemoglobin, a form of hemoglobin, in the blood. Methemoglobin cannot effectively release oxygen to body tissues, and this condition can lead to symptoms such as shortness of breath, cyanosis, and in severe cases, more serious complications. Certain drugs can induce methemoglobinemia as a side effect.

## Why the Correct Answer is Right
The correct answer involves identifying which of the listed drugs are known to cause methemoglobinemia. This condition is often associated with drugs that can oxidize hemoglobin to methemoglobin. Common culprits include certain local anesthetics (like **prilocaine**), some antibiotics, and other specific medications. The mechanism typically involves the drug or its metabolites acting on hemoglobin, leading to the formation of methemoglobin.

## Why Each Wrong Option is Incorrect
- **Option A:** This option would be incorrect if the drugs listed do not have a known association with methemoglobinemia. Without specific drug names, it's essential to consider the pharmacological properties of drugs that are commonly linked to this condition.
- **Option B:** Similarly, this option would be incorrect if the drugs it lists do not cause methemoglobinemia.
- **Option D:** This option would be incorrect if its listed drugs are not associated with the induction of methemoglobinemia.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **prilocaine** is a well-known cause of methemoglobinemia, especially at higher doses. This is because one of its metabolites, o-toluidine, is a potent inducer of methemoglobinemia. Clinicians should be cautious when using prilocaine, especially in patients with conditions that might predispose them to this side effect.

## Correct Answer: C.